Suppr超能文献

中风中的先天性炎症反应:机制与潜在治疗靶点。

Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets.

作者信息

Kim J Y, Kawabori M, Yenari M A

机构信息

Dept. of Neurology, University of California, San Francisco and Veterans Affairs Medical Center, San Francisco, California 4150 Clement Street, San Francisco, CA 94121, USA.

出版信息

Curr Med Chem. 2014;21(18):2076-97. doi: 10.2174/0929867321666131228205146.

Abstract

Stroke is a frequent cause of long-term disability and death worldwide. Ischemic stroke is more commonly encountered compared to hemorrhagic stroke, and leads to tissue death by ischemia due to occlusion of a cerebral artery. Inflammation is known to result as a result of ischemic injury, long thought to be involved in initiating the recovery and repair process. However, work over the past few decades indicates that aspects of this inflammatory response may in fact be detrimental to stroke outcome. Acutely, inflammation appears to have a detrimental effect, and anti-inflammatory treatments have been been studied as a potential therapeutic target. Chronically, reports suggest that post-ischemic inflammation is also essential for the tissue repairing and remodeling. The majority of the work in this area has centered around innate immune mechanisms, which will be the focus of this review. This review describes the different key players in neuroinflammation and their possible detrimental and protective effects in stroke. A better understanding of the roles of the different immune cells and their temporal profile of damage versus repair will help to clarify more effective modulation of inflammation post stroke.

摘要

中风是全球长期残疾和死亡的常见原因。与出血性中风相比,缺血性中风更为常见,它是由于脑动脉闭塞导致局部缺血,进而引起组织死亡。已知炎症是缺血性损伤的结果,长期以来人们认为炎症参与启动恢复和修复过程。然而,过去几十年的研究表明,这种炎症反应的某些方面实际上可能对中风预后有害。在急性期,炎症似乎具有有害作用,抗炎治疗已作为一种潜在的治疗靶点进行研究。在慢性期,有报告表明缺血后炎症对于组织修复和重塑也至关重要。该领域的大多数研究都集中在固有免疫机制上,这将是本综述的重点。本综述描述了神经炎症中不同的关键参与者及其在中风中可能产生的有害和保护作用。更好地理解不同免疫细胞的作用及其损伤与修复的时间特征,将有助于阐明中风后更有效的炎症调节方法。

相似文献

1
Innate inflammatory responses in stroke: mechanisms and potential therapeutic targets.
Curr Med Chem. 2014;21(18):2076-97. doi: 10.2174/0929867321666131228205146.
2
Inflammatory responses in brain ischemia.
Curr Med Chem. 2015;22(10):1258-77. doi: 10.2174/0929867322666150209154036.
3
The immunology of stroke: from mechanisms to translation.
Nat Med. 2011 Jul 7;17(7):796-808. doi: 10.1038/nm.2399.
4
Pivotal role of innate myeloid cells in cerebral post-ischemic sterile inflammation.
Semin Immunopathol. 2018 Nov;40(6):523-538. doi: 10.1007/s00281-018-0707-8. Epub 2018 Sep 11.
5
Targeting vascular inflammation in ischemic stroke: Recent developments on novel immunomodulatory approaches.
Eur J Pharmacol. 2018 Aug 15;833:531-544. doi: 10.1016/j.ejphar.2018.06.028. Epub 2018 Jun 20.
6
Inflammatory Disequilibrium in Stroke.
Circ Res. 2016 Jun 24;119(1):142-58. doi: 10.1161/CIRCRESAHA.116.308022.
7
Neuroinflammation: friend and foe for ischemic stroke.
J Neuroinflammation. 2019 Jul 10;16(1):142. doi: 10.1186/s12974-019-1516-2.
8
The Yin and Yang of innate immunity in stroke.
Biomed Res Int. 2014;2014:807978. doi: 10.1155/2014/807978. Epub 2014 Apr 30.
10
Glial Cells: Role of the Immune Response in Ischemic Stroke.
Front Immunol. 2020 Feb 26;11:294. doi: 10.3389/fimmu.2020.00294. eCollection 2020.

引用本文的文献

2
Reduction of inflammatory biomarkers underlies extracellular vesicle mediated functional recovery in an aged monkey model of cortical injury.
Front Aging Neurosci. 2025 Jul 9;17:1605144. doi: 10.3389/fnagi.2025.1605144. eCollection 2025.
4
Neutrophil-related immune-inflammatory biomarkers influence the early progression of medial medullary infarction.
Front Neurol. 2025 Feb 26;16:1528560. doi: 10.3389/fneur.2025.1528560. eCollection 2025.
7
Drug screening for ischemic stroke using larvae and adult zebrafish model: a review.
Lab Anim Res. 2025 Jan 2;41(1):1. doi: 10.1186/s42826-024-00232-4.
8
9
Neutrophil Lymphocyte Ratio Predicts Early Neurological Deterioration in Patients with Anterior Circulation Stroke.
Int J Gen Med. 2024 Nov 16;17:5325-5331. doi: 10.2147/IJGM.S472316. eCollection 2024.

本文引用的文献

2
Delayed administration of interleukin-1 receptor antagonist reduces ischemic brain damage and inflammation in comorbid rats.
J Cereb Blood Flow Metab. 2012 Sep;32(9):1810-9. doi: 10.1038/jcbfm.2012.101. Epub 2012 Jul 11.
5
FTY720, sphingosine 1-phosphate receptor modulator, selectively radioprotects hippocampal neural stem cells.
Neurosci Lett. 2012 May 16;516(2):253-8. doi: 10.1016/j.neulet.2012.04.004. Epub 2012 Apr 7.
6
Essential role of interleukin-6 in post-stroke angiogenesis.
Brain. 2012 Jun;135(Pt 6):1964-80. doi: 10.1093/brain/aws075. Epub 2012 Apr 3.
7
Neuroprotective mechanisms of hypothermia in brain ischaemia.
Nat Rev Neurosci. 2012 Feb 22;13(4):267-78. doi: 10.1038/nrn3174.
8
Purine nucleosides: endogenous neuroprotectants in hypoxic brain.
J Neurochem. 2012 May;121(3):329-42. doi: 10.1111/j.1471-4159.2012.07692.x. Epub 2012 Mar 14.
9
Fingolimod for multiple sclerosis.
N Engl J Med. 2012 Jan 26;366(4):339-47. doi: 10.1056/NEJMct1101691.
10
P2X7 receptor blockade prevents ATP excitotoxicity in neurons and reduces brain damage after ischemia.
Neurobiol Dis. 2012 Mar;45(3):954-61. doi: 10.1016/j.nbd.2011.12.014. Epub 2011 Dec 11.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验